Role of Ayurveda in the Management of Cerebral Palsy in the Children: A Critical Review

Authors

  • Narinder Sharma Nodal Officer, Government Ayurvedic Medical College Hospital Akhnoor, Jammu, Jammu and Kashmir, India. Author
  • Aman Gupta Medical Officer, Directorate of Ayush, Jammu and Kashmir, India. Author
  • Dheeraj Khajuria Assistant Professor, Department of Dravyaguna, Government Ayurvedic Medical College Akhnoor, Jammu, Jammu and Kashmir, India. Author

DOI:

https://doi.org/10.48165/IRJAY.2024.70505

Keywords:

Ayurvedic drugs, Cerebral palsy, Neuroprotective activity, Nootropic activity

Abstract

Introduction: A group of conditions collectively known as cerebral palsy (CP) impact a person’s mobility, balance,  and postural stability. Children with CP are more likely to have a motor handicap. Every 1000 live births, it happens  in 1.5–2.5 of them. When compared to infants born at term, the prevalence is noticeably higher in premature births. Material and Methods: In this review, search engines such as PubMed, Ayush Research Portal, Dhara, and Scopus  regarding Ayurvedic medicinal plants having Nootropic activity, Neuroprotective activity, and anticonvulsant activity  were used. Results: Different single Ayurvedic medicinal drugs were screened for having nootropic activity, neuroprotective  activity, and anticonvulsant activity. Discussion: These screened drugs may be used in the related conditions of CP, which in turn improves the quality  of life in pediatric patients. Conclusion: More intensive scientific review on CP is the need of the hour. The present review helps in day-to-day  clinical practice. A group of conditions known as cerebral palsy (CP) impacts a  person’s mobility, balance, and posture. The most prevalent motor disability in children is CP. The word cerebral refers to brain related matters. Palsy is a term used to describe muscle weakness  or dysfunction. A person’s inability to control their muscles due  to improper brain development or damage to the growing brain is  the cause of CP.[1] Although it does not necessarily result in severe  problems, CP is the primary cause of childhood disability in India.  A person with severe CP may require lifetime care or specialized  equipment, while someone with mild CP may not require any  assistance or may have minor issues like trouble walking. Since the  disorder is not progressive, it does not worsen with time, and in fact,  

Downloads

Download data is not yet available.

References

Available from: https://www.cdc.gov/ncbddd/cp/facts.html [Last accessed on 2024 Apr 26].

Available from: https://www.ninds.nih.gov/health-information/ disorders/cerebral-palsy [Last accessed on 2024 Apr 26]. 3. Hallman-Cooper JL, Rocha Cabrero F. Cerebral palsy. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538147 [Last accessed on 2022 Oct 10].

Available from: https://www.cerebralpalsyguide.com/cerebral-palsy [Last accessed on 2024 May 02].

Available from: https://www.ninds.nih.gov/health-information/ disorders/cerebral-palsy [Last accessed on 2024 May 02]. 6. Stough C, Downey LA, Lloyd J, Silber B, Redman S, Hutchison C, et al. Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial. Phytother Res 2008;22:1629-34. 7. Downey LA, Kean J, Nemeh F, Lau A, Poll A, Gregory R, et al. An acute, double-blind, placebo-controlled crossover study of 320mg and 640mg doses of a special extract of Bacopa monnieri (CDRI 08)

on sustained cognitive performance. Phytother Res 2013;27:1407-13. 8. Benson S, Downey LA, Stough C, Wetherell M, Zangara A, Scholey A. An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood. Phytother Res 2014;28:551-9. 9. Hannan MA, Haque MN, Munni YA, Oktaviani DF, Timalsina B, Dash R, et al. Centella asiatica promotes early differentiation, axodendritic maturation and synaptic formation in primary hippocampal neurons. Neurochem Int 2021;144:104957. 10. Gray NE, Harris CJ, Quinn JF, Soumyanath A. Centella asiatica modulates antioxidant and mitochondrial pathways and improves cognitive function in mice. J Ethnopharmacol 2016;180:78-86. 11. Rao SB, Chetana M, Uma Devi P. Centella asiatica treatment during postnatal period enhances learning and memory in mice. Physiol Behav 2005;86:449-57.

Xing D, Yoo C, Gonzalez D, Jenkins V, Nottingham K, Dickerson B, et al. Effects of acute ashwagandha ingestion on cognitive function. Int J Environ Res Public Health 2022;19:11852.

Choudhary D, Bhattacharyya S, Bose S. Efficacy and safety of ashwagandha (Withania somnifera (L.) Dunal) root extract in improving memory and cognitive functions. J Diet Suppl 2017;14:599-612.

Lalert L, Kruevaisayawan H, Amatyakul P, Ingkaninan K, Khongsombat O. Neuroprotective effect of Asparagus racemosus root extract via the enhancement of brain-derived neurotrophic factor and estrogen receptor in ovariectomized rats. J Ethnopharmacol 2018;225:336-41.

Sharma K, Bhatnagar M, Kulkarni SK. Effect of Convolvulus pluricaulis Choisy and Asparagus racemosus Willd on learning and memory in young and old mice: A comparative evaluation. Indian J Exp Biol 2010;48:479-85.

Rao VS, Rao A, Karanth KS. Anticonvulsant and neurotoxicity profile of Nardostachys jatamansi in rats. J Ethnopharmacol 2005;102:351-6.

Tandon VR, Gupta RK. An experimental evaluation of anticonvulsant activity of Vitex- negundo. Indian J Physiol Pharmacol 2005;49:199-205.

Verma S, Sinha R, Kumar P, Amin F, Jain J, Tanwar S. Study of Convolvulus pluricaulis for antioxidant and anticonvulsant activity. Cent Nerv Syst Agents Med Chem 2012;12:55-9.

Downloads

Published

2024-05-31

How to Cite

Sharma, N., Gupta, A., & Khajuria, D. (2024). Role of Ayurveda in the Management of Cerebral Palsy in the Children: A Critical Review . International Research Journal of Ayurveda and Yoga, 7(5), 22–25. https://doi.org/10.48165/IRJAY.2024.70505